CD8A and hepatocellular carcinoma: In the context of ICI therapy, there is a significant enrichment of cellular triads composed of mregDCs, CXCL13 + helper T (Th) cells, and PD-1hi progenitor CD8 + T cells within the HCC microenvironment.